Koyfin Home > Directory > Health Care > Aimmune Therap > Net Income

Aimmune Therap Net Income Chart (AIMT)

Aimmune Therap annual/quarterly Net Income from 2014 to 2020. Net income is calculated as sales less cost of goods sold, selling, general and administrative expenses, operating expenses, depreciation, interest, taxes and other expenses. This number appears on a company's income statement and is an important measure of how profitable the company is.
  • Aimmune Therap Net Income for the quarter ending June 06, 2020 was $-69m a 6.92% decrease of -5m year over year
  • Aimmune Therap Net Income for the last 12 months ending June 06, 2020 was $-287m a 16.87% decrease of -48m year over year
  • Aimmune Therap Annual Net Income for 2019 was $-248m a 15.19% decrease of -38m from 2018
  • Aimmune Therap Annual Net Income for 2018 was $-211m a 37.69% decrease of -79m from 2017
  • Aimmune Therap Annual Net Income for 2017 was $-131m a 38.45% decrease of -51m from 2016
Other Income Statement Metrics:
  • Aimmune Therap EBITDA for the quarter ending December 12, 2018 was $-58m a 14.28% decrease of -8m year over year
View Chart On Koyfin

Quarterly AIMT Net Income Data

06/2020$-69m
03/2020$-86m
12/2019$-67m
09/2019$-64m
06/2019$-63m
03/2019$-54m
12/2018$-57m
09/2018$-52m
06/2018$-53m
03/2018$-50m

Annual AIMT Net Income Data

2019$-248m
2018$-211m
2017$-131m
2016$-81m
2015$-36m
2014$-11m
2013$-5m